RAINBOW Study Shows Real Life Outcomes in AMD
Obtaining real life evidence is important for ophthalmologists, as the
outcomes achieved in randomised studies of antivascular endothelial
growth factor (VEGF) agents may not always translate into clinical practices.
Linked to this is a scarcity of real life evidence in treatment naïve patients.
Modern Medicine – September 2017
